Bioprocess Containers Market to reach $20.9 Billion by 2030; Growing demand for biologics including antibodies, vaccines, cell and gene therapies, rise in chronic diseases such as diabetes and cancer and growing adoption single use technology are pri

Bioprocess containers market size is expected to reach $20.9 billion by 2030 after growing at a CAGR of 27.9% during the forecast period 2024-2030 according to the latest market research report published by IndustryARC. Growing demand for biologics including antibodies, vaccines, cell and gene therapies, rise in  chronic diseases such as diabetes and cancer and growing adoption single use technology are poised to propel the demand, finds IndustryARC in its recent report, titled “Bioprocess containers Market – By Type (2D Bioprocess Containers, 3D Bioprocess Containers, Tank Liner BPC systems, Others), By Material (Polyethylene, Polyvinyl chloride (PVC), Ethylene Vinyl Acetate (EVA), Other Materials), By Form (Bags, Bottles, Single Use Containers, Others), By Capacity (Small Volume Containers (≤50L), Medium Volume Containers (50L to 500L), Large Volume Containers (≥500L)), By Application (Upstream Processing, Downstream Processing and Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Academic and Research Institutes, Hospitals and Clinics and Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030

The Asia-Pacific region is fastest growing in the pharmaceutical and biotechnology sectors, driven by increased healthcare expenditure, rising chronic diseases, and a focus on personalized medicine. Advancements in technology and regulatory support are facilitating faster drug development, while collaborations between local firms and global companies are enhancing innovation. According to Shanghai Fosun Pharmaceutical Group, the net profit of the parent company in the second quarter of 2024 increased by $5.29 million compared to the previous quarter, reaching a total of $92.29 million. As evident from above, the pharma and biotech sectors in the region are growing at a face pace necessitating the need for bioprocess containers.

Single-use technologies (SUT) in biopharmaceutical manufacturing refer to disposable systems that are designed for a single cycle of use, eliminating the need for cleaning and sterilization between batches. These technologies, including bioprocess containers, bioreactors, and filtration systems, offer significant advantages such as reduced operational costs, minimized contamination risks, and increased flexibility in production. SUT enables quicker turnaround times and scalability, making them particularly valuable in the rapidly evolving landscape of biologics and personalized medicine. As companies strive for more efficient and cost-effective manufacturing processes, the adoption of single-use technologies is becoming increasingly prevalent in the biopharma industry

The rising demand for biologics and biosimilars is a significant driver in the biopharmaceutical market, largely fueled by the growing prevalence of chronic diseases, advancements in biotechnology, and the increasing acceptance of these treatments among healthcare professionals and patients. Biologics, which include therapies derived from living organisms, offer innovative solutions for complex medical conditions, while biosimilars provide cost-effective alternatives to original biologic drugs. This surge in demand encourages pharmaceutical companies to invest in research and development, expand production capabilities, and adopt flexible manufacturing processes, such as single-use technologies, to meet the urgent need for effective and accessible therapies in the healthcare landscape.

Key companies profiled in the Bioprocess Containers Market are Lonza Group AG, Corning Incorporated, Entegris Inc., Parket Hannifin Corporation, Meissner Filtration Products Inc., Merck KGaA, Avantor Inc., Satorius AG, Thermo Fisher Scientific Inc., Cytiva and Others

Single-Use Bioprocessing Market - Single-Use Bioprocessing market is projected to reach $21.7 billion by 2027 at a CAGR of 17.6% during the forecast period 2024-2030. Due to the minimal need for sterilization and cleaning, along with the automation of processes through IoT and AI drive the market.

Large & Small-Scale Bioprocessing Market - Large & Small-Scale Bioprocessing market is projected to reach $30.32 billion by 2020 growing at a CAGR of 6.2% during the forecast period 2021-2026. The market is being driven primarily by an increase in demand for bioprocess container market.